Kalydeco (Vertex Pharmaceuticals Incorporated)
Welcome to the PulseAid listing for the Kalydeco drug offered from Vertex Pharmaceuticals Incorporated. This Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC],Chloride Channel Activation Potentiators [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Vertex Pharmaceuticals Incorporated |
NON-PROPRIETARY NAME: | ivacaftor |
SUBSTANCE NAME: | IVACAFTOR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC],Chloride Channel Activation Potentiators [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-01-31 |
END MARKETING DATE: | 0000-00-00 |
Kalydeco HUMAN PRESCRIPTION DRUG Details:
Item Description | Kalydeco from Vertex Pharmaceuticals Incorporated |
LABELER NAME: | Vertex Pharmaceuticals Incorporated |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2012-01-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51167-200_b8737c5a-6b1a-48a1-af69-b652becc7428 |
PRODUCT NDC: | 51167-200 |
APPLICATION NUMBER: | NDA203188 |
Other IVACAFTOR Pharmaceutical Manufacturers / Labelers: